Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Marker for Breast Cancer

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
Research says it soon may be possible to gauge individual risk for disease, and eventually to treat it.

An international scientific collaborative led by the Harvard Stem Cell Institute’s Kornelia Polyak has discovered why women who give birth in their early 20s are less likely to develop breast cancer eventually than women who don’t, triggering a search for a way to confer this protective state on all women.

The researchers are now testing p27, a mammary gland progenitor marker, on tissue samples collected from thousands of women over decades — women whose medical histories have been followed extremely closely — to see if it is an accurate breast cancer predictor in a large population. If the hypothesis is confirmed, which appears likely within a few months, Polyak says the commercial development of a clinical test for breast cancer risk would follow.

In a paper just published in the journal Cell Stem Cell, the researchers describe how a full-term pregnancy when a woman is in her early 20s reduces the relative number and proliferative capacity of mammary gland progenitors — cells that have the ability to divide into milk-producing cells — making them less likely to acquire mutations that lead to cancer.

By comparing numerous breast tissue samples, the scientists found that women at high risk for breast cancer, such as those who inherit a mutated BRCA1 or BRCA2 gene, have higher-than-average numbers of mammary gland progenitors. In general, women who carried a child to full term had the lowest populations of mammary gland progenitors, even when compared with cancer-free women who had never been pregnant. In addition, in women who gave birth relatively early but later developed breast cancer, the number of mammary gland progenitors was again observed to be higher than average.

“The reason we are excited about this research is that we can use a progenitor cell census to determine who’s at particularly high risk for breast cancer,” said Polyak, a Harvard Stem Cell Institute principal faculty member and a Harvard Medical School professor at the Dana-Farber Cancer Institute. “We could use this strategy to decrease cancer risk because we know what regulates the proliferation of these cells, and we could deplete them from the breast.”

Research shows that two trends are contributing to an increase in the number of breast cancer diagnoses, a rise in obesity and the ever-increasing number of women postponing childbearing. The scientists’ long-range goal is to develop a treatment that would mimic the protective effects of early childbearing.

The research, which took five years to complete, began with conversations between Polyak and Saraswati Sukumar, a professor at Johns Hopkins University School of Medicine. The two scientists formed collaborations with clinicians at cancer centers that see large numbers of high-risk women, in order to obtain breast tissue samples. They also worked with genomics experts and bioinformaticians to analyze gene expression in different breast cell types. At times, Polyak and Sukumar had trouble gaining cooperation for the study, which is unique in the breast cancer field for its focus on risk prediction and prevention.

“In general, people who study cancer always want to focus on treating the cancer. But, in reality, preventing cancer can have the biggest impact on cancer-associated morbidity and mortality,” Polyak said. “I think the mentality has to change because breast cancer affects so many women, and even though many of them are not dying of breast cancer, there’s a significant personal and societal burden.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Weapon Against Breast Cancer
Molecular marker in healthy tissue can predict a woman’s risk of getting the disease, research says.
Thursday, April 07, 2016
Delivering Hope in Ovarian Cancer
Gene therapy blocked chemoresistant tumor growth in mice.
Tuesday, August 11, 2015
Beyond Average
Researchers have created new platforms to genetically barcode tens of thousands of cells at a time allowing unprecedented detail to be uncovered when studying whole tissue samples.
Tuesday, May 26, 2015
Viral Infections May Have Met Their Match
Researchers ID protein that sets off body's response to fight infection.
Friday, November 29, 2013
HC-LITT to Provide Stabilization Technology to the Harvard Research Community
Harvard research community will have access to the Denator’s Stabilizor™ system for stabilizing biological samples.
Friday, April 24, 2009
Molecule by Molecule, Assay Shows Real-time Gene Activity
The technique could provide Researchers with unprecedented insights into gene expression in living cells.
Thursday, March 23, 2006
Scientific News
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
DNA Barcodes Gone Wild
A team of researchers at University of Toronto’s Donnelly Centre and Sinai Health System’s Lunenfeld-Tanenbaum Research Institute (LTRI) has developed a new technology that can stitch together DNA barcodes inside a cell to simultaneously search amongst millions of protein pairs for protein interactions.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Grant to Fund Million Peaks Project
The European Research Council (ERC) has awarded a prestigious Advanced Grant to Prof. Peter Schoenmakers, Prof. Albert Polman and Prof. Huib Bakker, all three of whom work at the University of Amsterdam (UvA).
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!